Stamford, CT -- (SBWIRE) -- 01/15/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Control4 Corp (NASDAQ:CTRL), Echelon Corporation (NASDAQ:ELON), Ibio Inc (NYSEMKT:IBIO), MediciNova, Inc. (NASDAQ:MNOV)
Control4 Corp (NASDAQ:CTRL) opened the session at $21.20, trading in a range of $20.60 - $29.30. The stock showed a positive performance of +37.56% in the last trading session from its previous close of $18.53 and closed at $25.49. The stock traded on a volume of 1.54 million shares and the average volume of the stock remained 74,694 shares. Control4 Corporation is a provider of automation and control solutions for the connected home. The Company provides its consumers with the ability to integrate music, video, lighting, temperature, security, communications and other functionalities into a unified home automation solution. The Company's solution functions as the operating system of the home, making connected devices work together to control, automate and personalize the homes of its consumers. Control4 Home Operating System (C4 OS) is one of the product line of the Company.
For How Long CTRL will Fight for Profitability? Read This Trend Analysis report
Echelon Corporation (NASDAQ:ELON) traded 3.20 million shares in the last business day while the average volume of the stock remained 117,840 shares. The stock showed a positive movement of +35.68% to end at $3.08. The 52 week range of the stock remained $1.99 - $3.19. Echelon Corporation (Echelon) develops, markets and supports an open standard, multi-application energy control networking platform. The Company's energy control networking platform consists of three tiers, or categories, of products: a device tier, a control node tier, and an enterprise tier. At the device tier, devices such as load controllers, lighting ballasts, meters and thermostats, embed the Company's Free Topology (FT) or Power line (PL) smart transceivers. These devices are managed by control nodes, in this case Echelon's Smart Servers. Echelon offers, directly and through its partners globally, a range of products and services.
For How Long ELON’s Gloss will Attract Investors? Find out via this report
Ibio Inc (NYSEMKT:IBIO) reported 1.93 million shares were exchanged during the last trade, while the average volume is about 232,417 shares. The stock escalated +34.79% and finished the day at $0.585. The beta of the stock is recorded at 1.82. iBio, Inc. (iBio) is a biotechnology company focused on commercializing its technologies, the iBioLaunch platform for vaccines and therapeutic proteins, as well as the iBioModulator platform for vaccine enhancement. Vaccine candidates on its platform are applicable to newly emerging strains of hemagglutinin type 1 and neuraminidase type 1 (H1N1), swine-like influenza, hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza, yellow fever, and anthrax.
For How Long IBIO’s Gloss will Attract Investors? Find out via this report
MediciNova, Inc. (NASDAQ:MNOV) shares rose, +32.09 percent from its previous close of $2.15 to close at $2.84. Traded with volume of 8.29 million shares in the prior session and the average volume of the stock remained 31,796 shares. MediciNova, Inc. is a development-stage biopharmaceutical company focused on acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs with a focus on the United States market. Through strategic alliances, primarily with Japanese pharmaceutical companies, it holds rights to a diversified portfolio of clinical and preclinical product candidates.
Why Should Investors Buy MNOV After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)